Solid Dose Form of Metformin with Ethyl Eicosapentaenoic Acid Does Not Improve Metformin Plasma Availability

BACKGROUND: The purpose of the study was to investigate effects of ethyl eicosapentaenoic acid on pharmacokinetics of metformin. Pharmacokinetic profiles of metformin and ethyl eicosapentaenoic acid when delivered separately or together in solid dose form were investigated and compared to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Jeffrey H., Johnson, William D., Greenway, Frank L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755534/
https://www.ncbi.nlm.nih.gov/pubmed/26893954
http://dx.doi.org/10.4236/pp.2016.71005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755534/
https://www.ncbi.nlm.nih.gov/pubmed/26893954
http://dx.doi.org/10.4236/pp.2016.71005

Ejemplares similares